|
|
Volumn 9, Issue , 2013, Pages 165-175
|
|
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
a a |
|
Author keywords
antiarrhythmic drug; atrial fibrillation; atrial selective K+ currents; Na+ channel block; ventricles
|
|
Indexed keywords
ANISOLE DERIVATIVE;
ANTIARRHYTHMIC AGENT;
POTASSIUM CHANNEL BLOCKING AGENT;
PYRROLIDINE DERIVATIVE;
SODIUM CHANNEL BLOCKING AGENT;
VERNAKALANT;
ACTION POTENTIAL;
ANIMAL;
ATRIAL FIBRILLATION;
DRUG EFFECTS;
HEART MUSCLE CONDUCTION SYSTEM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
REFRACTORY PERIOD;
TIME;
TREATMENT OUTCOME;
ACTION POTENTIALS;
ANIMALS;
ANISOLES;
ANTI-ARRHYTHMIA AGENTS;
ATRIAL FIBRILLATION;
HEART CONDUCTION SYSTEM;
HUMANS;
INFUSIONS, INTRAVENOUS;
POTASSIUM CHANNEL BLOCKERS;
PYRROLIDINES;
REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL;
SODIUM CHANNEL BLOCKERS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84890117428
PISSN: None
EISSN: 11782048
Source Type: Journal
DOI: 10.2147/VHRM.S43720 Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|